Hoʻokolohua blockers

Ai 'e pili ana i keia pae ana o' ona i hoʻohana e hana i ka nń ku naau maʻi: coronary naau maʻi (me ka huʻi myocardial infarction, prophylaxis o angina pectoris), hypertension, tachyarrhythmias, maʻi naʻau ole.

Hoʻokolohua blockers hana me nâ hakaka o noradrenaline, adrenaline a me nā waiwai i i ka waiwai o ka Hoʻokolohua adrenoceptor agonists ma.

Hopenaʻoi loa o ka hui ana ma keia pae hilinaʻi nui ma luna o ka moku'āina o ke aloha o ko mākou hopohopo nenoaiu. Me ka ulu ana o keia 'oihana, hoʻomāhuahua ai waiwai lawelawe ma ke kanaka kino. A Hope versa. I pau, kā lākou laulā maoli he me nā pathologies o ka naau, i mea pu ma ka stressful rula, thyrotoxicosis, paka (nicotine i piʻi pū kōkua aloha o leo).

Lāʻau lapaʻau waiwai haawi pharmacological pūʻulu mea o ka ekolu hoailona ia mea: he poʻe'ē he, pili-e wae, a e wae. Hoʻokolohua blockers: atenolol, metoprolol, acebutolol, bisoprolol, esmolol - e pili ana i ke kolu o ka type. Ole-e wae ai 'poe ma ka propranolol, nadolol, pindolol, penbutalolom, timolol, oxprenolol, sotalol. Hoʻohuihui blockers: labetalol, carvedilol.

palapala noi

Ke iniiaiie cardiac pathology, ma i hoʻohana Hoʻokolohua blockers - ischemic naʻau maʻi. Keʻano papa hana o ka hana o ka waiwai o ka Hoʻokolohua adrenergic blockade, e alakai ana i ka emi ana o ka naau oihana: contractility, conduction, excitability, automatism. I ka hopena o ka ka ho'ēmiʻana o ka naʻau, i mea he emi i loko o ka naʻau ana, hahau ka leo a me ka cardiac auaiaea. Myocardial oxygen ma koi ua nui hoemi, a pela e hōʻoiaʻiʻo ka hoʻokō Kāohiʻana o ka ho'āhewa wale angina. Ai 'o keia pae ho'ēmi i kā ka pilikia o ka ulia make i loko o nā mea maʻi i i ae aku myocardial infarction.

No ka cupping tachyarrhythmias mea i hoʻohana Hoʻokolohua adrenoblokatorry. Ke emi ma ka naau uku, ka meheu o atrioventricular conduction wehewehe i ka pākōlea hopena. A oi haʻi hopena o ka ai 'ua malama ia ma ka alo o atrial arrhythmias.

Lāʻau lapaʻau 'ona a i Hoʻokolohua wahi hana e pili ana i kekahi o elima papa o antihypertensive konohiki. Ka mea, i hoʻohana 'ia e hana i kekahi kahua o ka hypertension, e like me ia no ka iapaau ana o symptomaticʻano o ka maʻi. Keʻano papa hana o ka hana o ka Hoʻokolohua blockers ua i mai o ka eha eiiiiiaiou: hoemiia naau hana, suppression o ka renin-angiotensin'ōnaehana, ua hakumakuma i ka leo o ka vasomotor oaio, hoemi i ka huina oʻike ākea ia'ku o ke koko.

No ka iapaau ana o ka maʻi naau hoʻokō 'ole' blockers i hoʻohana. Kēia pūʻulu o ai 'ua wehe excessive ole o ke aloha o ko mākou hopohopo'ōnaehana i ka naau. Kēia ho'ēmi i kā ka adverse kanawai o ka epinephrine a me norepinephrine ma luna o ka naʻau, emi ka ha awina o ka Hoʻokolohua adrenergic receptors, ka meheu o ka naau kōmi. Eia naʻe, hoʻohana a excessive nā māhele o ka ai 'i ke kaupaonaʻana i kaʻikepili naʻau ole.

i Hoʻokolohua blockers mea hoʻohana ka pono no ka iapaau ana o ka hamama-huina glaucoma. Ka mea, kōkua hōʻemi loli secretion o ka ciliary kino. Penei, ka hōʻemiʻana o intraocular ka puʻuwai, a me ka maʻi symptoms nalo.

No ka iapaau ana o ka migraine ho'āhewa wale hoʻohana metoprolol, atenolol, timolol a me ka nadolol. Kā lākou hana ua wehewehe ma kekahi spasm o na ipu cerebral, ai 'agonistic haʻawina ma luna o ka serotonin receptors i loko o ka Central ko mākou hopohopo nenoaiu.